Literature DB >> 2510239

Enhanced interferon-gamma production by lymphocytes induced by a mitogen from mycoplasma arthritidis in patients with ankylosing spondylitis.

M Seitz1, E M Lemmel, J Homfeld, H Kirchner.   

Abstract

We have examined proliferation of and interferon-gamma (IFN-gamma) production by peripheral blood lymphocytes induced by a purified mitogen derived from mycoplasma arthritidis (MAS) in patients with seronegative spondylo-arthropathies and healthy individuals. In all patients and healthy controls MAS exerted a potent nonspecific lymphoproliferation. In contrast, only patients with ankylosing spondylitis (ASp) showed a strong IFN-gamma production after stimulation with MAS. The maximal IFN-gamma response was observed in HLA-B27+/HLA-DQw3+ patients. However, healthy controls with the HLA-DQw3 haplotype with or without the presence of HLA-B27 exhibited also a slight but statistically not significant increase of IFN-gamma production. Moreover, in this study we have found an enhanced frequency of HLA-DQw3 in patients with ASp and reactive arthritis. This immunogenetic association explains the enhanced lymphocyte reactivity in these inflammatory rheumatic disorders to mycoplasmal antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510239     DOI: 10.1007/bf00270250

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Biochemical characterization of the T-cell mitogen derived from Mycoplasma arthritidis.

Authors:  H Kirchner; G Brehm; W Nicklas; R Beck; F Herbst
Journal:  Scand J Immunol       Date:  1986-09       Impact factor: 3.487

2.  New York clinical criteria for ankylosing spondylitis. A statistical evaluation.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

3.  Mycoplasma infections as models of chronic joint inflammation.

Authors:  B C Cole; G H Cassell
Journal:  Arthritis Rheum       Date:  1979-12

4.  Unusual reactivity of lymphocytes from patients with ankylosing spondylitis to mitogen derived from Mycoplasma arthritidis.

Authors:  M Seitz; B Gaber; W Nicklas; H Kirchner
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

5.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. III. Ir gene control of lymphocyte transformation correlates with binding of the mitogen to specific Ia-bearing cells.

Authors:  B C Cole; R A Daynes; J R Ward
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

6.  Induction of interferon gamma in mouse spleen cells by culture supernatants of mycoplasma arthritidis.

Authors:  H Kirchner; W Nicklas; D Giebler; K Keyssner; R Berger; E Storch
Journal:  J Interferon Res       Date:  1984

7.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. II. Cellular requirements for T cell transformation mediated by a soluble Mycoplasma mitogen.

Authors:  B C Cole; G J Sullivan; R A Daynes; I A Sayed; J R Ward
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

8.  Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas.

Authors:  B C Cole; J C Overall; P S Lombardi; L A Glasgow
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. I. Transformation is associated with an H-2-linked gene that maps to the I-E/I-C subregion.

Authors:  B C Cole; R A Daynes; J R Ward
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Lymphoproliferation induced in mouse spleen cells by Mycoplasma arthritidis mitogen. Reversal of the defect of nonresponder mice.

Authors:  H Kirchner; D Giebler; K Keyssner; W Nicklas
Journal:  Scand J Immunol       Date:  1984-08       Impact factor: 3.487

View more
  3 in total

1.  Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.

Authors:  J M Brand; P Neustock; A Kruse; L Alvarez-Ossorio; A Schnabel; H Kirchner
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

Review 2.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

3.  An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation.

Authors:  Amity R Roberts; Matteo Vecellio; Liye Chen; Anna Ridley; Adrian Cortes; Julian C Knight; Paul Bowness; Carla J Cohen; B Paul Wordsworth
Journal:  Ann Rheum Dis       Date:  2016-02-25       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.